buy on any drops29 Apr 2020 18:06
This has massive potential and not just covid:
Prior to the appearance of COVID-19, Hemogenyx had been working independently and with a number of pharmaceutical company partners to utilize the exceptional features of ApbHC to identify and isolate human neutralizing antibodies for use as antiviral therapies. The Company's methodology is generally applicable to new pathogens including viruses, as previously described in the Company's original announcement of the development of ApbHC.
With the outbreak of COVID-19, the Company concluded that it would potentially be applicable to the SARS-CoV-2 virus. As part of its studies, Hemogenyx will transplant cells from blood samples from patients who are either recovering or have already recovered from COVID-19 into its ApbHC humanized mice. The process will allow the Company's scientists to recreate a set of anti-SARS-CoV-2 virus antibodies which could be used for the treatment of COVID-19